This is a YouTube video titled "Senolytics: Targeting Senescent Cells" containing a monologue or lecture-style explanation about senolytic therapies, including compounds like fisetin, dasatinib, quercetin, and Foxo4DRI, as well as the effects of SGLT2 drugs on senescent cell burden. The content appears to be educational or informational, focusing on the modulation of senescent cells for health benefits.
So there are senolytics. So testing to understand. The point is, testing to understand what your senescent cell burden is becomes important. And then you can modulate it with things like fisetin, dasatinib, and quercetin as a combination. Individually, they don't do as much as they do together. There's a peptide called Foxo4DRI, which is actually quite expensive, that will take a senescent cell and instruct it to actually kill itself. Right. Undergo apoptosis. So these things are out there, and then it's come out that sglt, two drugs that are used now for diabetes that cause us to not reabsorb glucose through the kidney, actually, you excrete it out through the urine. Turns out they have a benefit of lowering senescent cell burden also, which is. Yeah, we've seen that.
